Back to Search Start Over

Safety and efficacy of a hydroxypropyl guar/polyethylene glycol/propylene glycol-based lubricant eye-drop in patients with dry eye

Authors :
Abayomi Ogundele
Marc Labetoulle
Christophe Baudouin
Elisabeth M. Messmer
Pierre-Jean Pisella
AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre)
Ludwig Maximilians University of Munich
Hôpital Bretonneau
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bretonneau
Infectiologie et Santé Publique (UMR ISP)
Institut National de la Recherche Agronomique (INRA)-Université de Tours
Alcon Research
Partenaires INRAE
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO)
Institut National de la Recherche Agronomique (INRA)-Université de Tours (UT)
Source :
British Journal of Ophthalmology, British Journal of Ophthalmology, BMJ Publishing Group, 2017, 101 (4), pp.487-492. ⟨10.1136/bjophthalmol-2016-308608⟩
Publication Year :
2017
Publisher :
HAL CCSD, 2017.

Abstract

Aims To demonstrate non-inferiority of a hydroxypropyl guar/polyethylene glycol/propylene glycol lubricating eye-drop (HPG/PEG/PG) compared with an osmoprotective carboxymethylcellulose/glycerine eye-drop (O/CMC) for ocular surface staining. Methods This was a multicentre, randomised, observer-masked, parallel-group study. Adults with dry eye instilled HPG/PEG/PG/ or O/CMC 4 times daily for 35 days and then as needed through day 90. Total ocular surface staining (TOSS) score changes from baseline and Impact of Dry Eye on Everyday Life (IDEEL) treatment satisfaction module scores were assessed. Non-inferiority, based on TOSS score change from baseline, was concluded if the upper limit of the 2-sided CI was Results Mean±SD patient age was 64.4±13.7 years; 94 patients were randomised to treatment (HPG/PEG/PG, n=46; O/CMC, n=48). Mean±SE TOSS score change from baseline to day 35 was −2.2±0.33 with HPG/PEG/PG and −1.7±0.47 with O/CMC (treatment difference, −0.47±0.47; p=0.38), and the non-inferiority criterion was met. IDEEL treatment satisfaction scores were similar between groups at day 35 and day 90. The most frequently reported adverse event was eye irritation (HPG/PEG/PG, n=2; O/CMC, n=3). Conclusions HPG/PEG/PG and O/CMC reduced ocular surface damage, and HPG/PEG/PG was non-inferior to O/CMC. Both treatments were effective, convenient and well tolerated. Trial registration number NCT01863368, Results.

Details

Language :
English
ISSN :
00071161 and 14682079
Database :
OpenAIRE
Journal :
British Journal of Ophthalmology, British Journal of Ophthalmology, BMJ Publishing Group, 2017, 101 (4), pp.487-492. ⟨10.1136/bjophthalmol-2016-308608⟩
Accession number :
edsair.doi.dedup.....bdbb8ddc54941783e4299f352c3daa61